Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G Feb 11, 2022 FIRST LIGHT ACQUISITION GROUP, INC.
SC 13G Feb 11, 2022 SC 13G
SC 13G Feb 8, 2022 FORM SC 13G
SC 13G/A Feb 3, 2022 FIRST LIGHT ACQUISITION GROUP, INC.
10-Q Nov 12, 2021 FORM 10-Q
8-K Oct 28, 2021 8-K
SC 13G Oct 26, 2021
SC 13G Sep 24, 2021 SC 13G
SC 13G Sep 24, 2021 FIRST LIGHT ACQUISITION GROUP, INC.
SC 13G Sep 24, 2021 SCHEDULE 13G
8-K Sep 20, 2021 8-K
8-K Sep 15, 2021 8-K
3/A Sep 14, 2021 FORM 3/A
424B4 Sep 13, 2021 424B4
EFFECT Sep 9, 2021
3 Sep 9, 2021 FORM 3
3 Sep 9, 2021 FORM 3
3 Sep 9, 2021 FORM 3
3 Sep 9, 2021 FORM 3
3 Sep 9, 2021 FORM 3
3 Sep 9, 2021 FORM 3
CERT Sep 9, 2021 NYSE CERTIFICATION
8-A12B Sep 9, 2021 8-A12B
CORRESP Sep 7, 2021
CORRESP Sep 7, 2021
← Newer Page 16 of 17 · 406 filings Older →